Inflammasome Signaling Antibodies

Inflammasomes are multi-protein complexes whose activity has been implicated in physiological and pathological inflammation. The hallmarks of inflammasome activation are the secretion of the mature forms of caspase-1 and interleukin-1β (IL-1β) from cells of the innate immune system.

An inflammasome represents a high molecular weight complex that activates inflammatory caspases and cytokines of the IL-1 family (IL-1β, IL-18 and depending on the stimulus also IL-1α). Several inflammasomes have been described which contain different sensor proteins such as NLRP1 (NALP1), NLRP3 (NALP3), IPAF (NLRC4), NLRP6 (NALP6), RIG-I and AIM-2 (absent in melanoma 2). Most of these inflammasomes require the adapter protein Asc (apoptosis-associated specklike protein containing a caspase recruitment domain) to recruit caspase-1 to the inflammasome complex. Upon binding to the inflammasome caspase-1 is cleaved and activated, leading to cleavage of its various targets and causing maturation and secretion of the pro-inflammatory IL-1β. Inflammasomes can be activated through multiple signals including live bacteria, microbial toxins, xeno-compounds, cytoplasmic pathogen-associated molecular patterns (PAMPs) and/or endogenous danger signals (DAMPs).

Inflammasome activity has been causally linked to the induction of numerous inflammatory responses, which can be either beneficial or harmful to the organism. Beneficial responses arise by maintaining homeostatic tissue function (detection and repair of tissue damages after trauma or pathogen invasion). Among the harmful inflammatory responses are particle-induced sterile inflammation, caused by host-derived particles such as monosodium urate (MSU) crystals, which are involved in the pathogenesis of gout, as well as environmental and industrial particles such as asbestos, silica and metallic nanoparticles, which include lung inflammation upon inhalation. Accumulating evidence also implicates inflammasome activity in numerous other diseases, including cancer and the development of metabolic diseases like type 2 diabetes, atherosclerosis and inflammatory bowel diseases. Beneficial effects for the host include the enhancement of vaccine efficacy.

Inflammasomes Activation & Signaling
Download the Inflammasome™ Wallchart.

Specific Caspase-1 Detection


Cat. No.DescriptionAmountBrand
AG-20B-0044-C100anti-Caspase-1 (p10) (mouse), mAb (Casper-2)100 ugAdipoGen
AG-20B-0044B-C100anti-Caspase-1 (p10) (mouse), mAb (Casper-2) (Biotin)100 ugAdipoGen
AG-20B-0042-C100anti-Caspase-1 (p20) (mouse), mAb (Casper-1)100 ugAdipoGen
AG-20B-0042B-C100anti-Caspase-1 (p20) (mouse), mAb (Casper-1) (Biotin)100 ugAdipoGen
AG-20B-0048-C100anti-Caspase-1 (p20) (human), mAb (Bally-1)100 ugAdipoGen
AG-20B-0048B-C100anti-Caspase-1 (p20) (human), mAb (Bally-1) (Biotin)100 ugAdipoGen
AG-CP3-0002-M001Z-VAD-FMK (Cell permeable) [187389-52-2 ]1 mgAdipoGen
AG-CP3-0002-M005Z-VAD-FMK (Cell permeable) [187389-52-2 ]5 mgAdipoGen
AG-CP3-0006-M001Q-VD-OPh [1135695-98-5]1 mgAdipoGen
AG-CP3-0006-3001Q-VD-OPh [1135695-98-5]3 x 1 mgAdipoGen
AG-CP3-0006-M005Q-VD-OPh [1135695-98-5]5 mgAdipoGen
AG-46B-0003-KI01Caspase-1 (mouse) Matched Pair Detection Set1 setAdipoGen
AG-45B-0002-KI01Caspase-1 (mouse) ELISA Kit96 wellsAdipoGen

Standard Inflammasomes Signaling Antibodies


Cat. No.DescriptionAmountBrand
Nod-like Receptors (NLRs)
AG-20B-0045-C100anti-NAIP1/2/5 (mouse), mAb (Naipa-1)100 ugAdipoGen
AG-25B-0005-C100anti-NLRP1/NALP1 (human), pAb (AL176)100 ugAdipoGen
AG-20B-0014-C100anti-NLRP3/NALP3, mAb (Cryo-2)100 ugAdipoGen
AG-20B-0006-C100anti-NLRP3/NALP3 (mouse), mAb (Cryo-1)100 ugAdipoGen
AG-20B-0046-C100anti-NLRP6/NALP6 (human), mAb (Clint-1)100 ugAdipoGen
AG-25B-0021-C100anti-NLRP12/NALP12 (human), pAb (AL236)100 ugAdipoGen
AG-25B-0013-C050anti-Nod1 (human), pAb (AL184)50 ugAdipoGen
RIG-like Helicases (RLHs) – Antiviral Signaling
AG-20B-0009-C100anti-RIG-I, mAb (Alme-1)100 ugAdipoGen
AG-20B-0009B-C100anti-RIG-I, mAb (Alme-1) (Biotin)100 ugAdipoGen
AG-20B-0004-C100anti-Cardif (human), mAb (Adri-1)100 ugAdipoGen
AG-25B-0001-R100anti-MDA5 (mouse), pAb (AL180)100 ulAdipoGen
AG-20B-0013-C100anti-MDA5 (human), mAb (Hely-1)100 ugAdipoGen
AG-20B-0001-C100anti-NS3 (HCV), mAb (1B6)100 ugAdipoGen
AG-20B-0002-C100anti-NS5B (HCV), mAb (5B-3B1)100 ugAdipoGen
AG-20B-0003-C100anti-NS5B (HCV), mAb (blocking) (5B-12B7)100 ugAdipoGen
Cytosolic DNA Sensor
AG-20B-0040-C100anti-AIM2 (human), mAb (3B10)100 ugAdipoGen
Signaling Antibodies
AG-25B-0006-C100anti-Asc, pAb (AL177)100 ugAdipoGen
AG-25B-0006PF-C100anti-Asc, pAb (AL177) (preservative free)100 ugAdipoGen
AG-25B-0006TS-C100anti-Asc, pAb (AL177) (ATTO 647N)100 ugAdipoGen
AG-25B-0020-C100anti-Pyrin (human), pAb (AL196)100 ugAdipoGen
AG-25B-0011-R050anti-TRAM (human), pAb (AL239)50 ulAdipoGen
AG-25B-0008-C050anti-TRIF (human), pAb (AL227)50 ugAdipoGen
Cytosolic PAMPs Sensors
AG-20B-0060-C100anti-Caspase-4 /11 (p20), mAb (Flamy-1)100 ugAdipoGen
AG-20B-0060B-C100anti-Caspase-4 /11 (p20), mAb (Flamy-1) (Biotin)100 ugAdipoGen
AG-20B-0061-C100anti-Caspase-11 (p20) (mouse), mAb (Flamy-2)100 ugAdipoGen

Inflammasome Activators


Cat. No.DescriptionAmountBrand
AG-40B-0095-C100Flagellin100 ugAdipoGen
AG-40B-0025-C010Flagellin (high purity)10 ugAdipoGen
AG-40B-0125-C010Flagellin (rec.)10 ugAdipoGen
AG-40B-0126-C010Flagellin (NLRC4 Mutant) (rec.)10 ugAdipoGen
AG-40B-0127-C010Flagellin (TLR5 Mutant) (rec.)10 ugAdipoGen
AG-CR1-3950-M002Monosodium urate (crystals) [1198-77-2]2 mgAdipoGen
AG-CR1-3951-M010Monosodium urate (ready-to-use) [1198-77-2]10 mgAdipoGen
AG-CN2-0020-M005Nigericin . sodium salt [28643-80-3]5 mgAdipoGen
AG-CN2-0489-M250N-Acetyl-D-glucosamine [7512-17-6]250 mgAdipoGen
AG-CR1-3582-M005R-848 [144875-48-9]5 mgAdipoGen

Inflammasome “Priming” Activators

Priming of the NLRP3 Inflammasome

The most prominent function of the NLRP3 inflammasome is the processing and activation of pro-interleukin-1β (pro-IL-1β). Yet most cells do not express pro-IL-1β and thus prior expression of pro-IL-1β is required. This can be achieved by stimulating receptors such as TLRs (e.g. LPS), NODs or TNF-Rs (e.g. TNF-α) that activate NF-κB and initiate pro-IL-1β transcription. This process of pro-IL-1β induction is called priming (Signal 1). Priming also induces NF-κB-dependent transcription of NLRP3. An additional stimulus (Signal 2) results in the activation of the NLRP3 inflammasome and subsequent initiation of downstream signaling. In the absence of priming, NLRP3 inflammasome-dependent caspase-1 activation can also be observed, but IL-1β secretion is absent.

Cat. No.DescriptionAmountBrand
AG-40B-0006-C010TNF-alpha, Soluble (human) (rec.)10 ugAdipoGen
AG-40B-0019-C010TNF-alpha (human) (multimeric) (rec.)10 ugAdipoGen
AG-40B-0021-C010TNF-alpha (mouse) (multimeric) (rec.)10 ugAdipoGen
IAX-100Lipopolysaccharides (LPS)1 mgInnaxon

Inflammasome Signaling-related Proteins & Antibodies


Cat. No.DescriptionAmountBrand
AG-40B-0023-C010IL-1beta (human) (rec.) (untagged)10 ugAdipoGen
AG-40B-0086-C010IL-1beta (mouse) (rec.) (untagged)10 ugAdipoGen
AG-40B-0024-C050IL-1R1 (human):Fc (human) (rec.)50 ugAdipoGen
AG-20B-0050-C100anti-IL-1alpha (mouse), mAb (Bamboo-1)100 ugAdipoGen
AG-20B-0058-C100anti-IL-1alpha (mouse), mAb (Bamboo-2)100 ugAdipoGen
AG-45B-0003-KI01IL-1alpha (mouse) ELISA Kit96 wellsAdipoGen
AG-46B-0004-KI01IL-1alpha (mouse) Matched Pair Detection Set1 setAdipoGen
AG-20B-0064-C100anti-IL-1alpha (p18) (mouse), mAb (Teo-1)100 ugAdipoGen
AG-27B-0011-C100anti-IL-1R2 (mouse), mAb (rec.) (Praxy-1-1)100 ugAdipoGen

Microtubule Antibodies


Cat. No.DescriptionAmountBrand
AG-20B-0068-C100anti-alpha-Tubulin (acetylated), mAb (TEU318)100 ugAdipoGen
AG-20B-0020-C100anti-Polyglutamylation Modification, mAb (GT335)100 ugAdipoGen
AG-20B-0020B-C100anti-Polyglutamylation Modification, mAb (GT335) (Biotin)100 ugAdipoGen
AG-25B-0030-C050anti-Polyglutamate chain (polyE), pAb (IN105)50 ugAdipoGen

Inflammasome Inhibitors


Cat. No.DescriptionAmountBrand
AG-CR1-3616-M025(R)-3-Hydroxybutyric acid [625-72-9]25 mgAdipoGen
AG-CR1-3617-M025(S)-3-Hydroxybutyric acid [6168-83-8]25 mgAdipoGen
AG-CN2-0458-M001Arglabin [84692-91-1]1 mgAdipoGen
AG-CR1-0013-M010BAY 11-7082 [19542-67-7]10 mgAdipoGen
AG-CR1-3567-M001Colcemid [477-30-5]1 mgAdipoGen
AG-CN2-0048-G001Colchicine [64-86-8]1 gAdipoGen
BVT-0447-M001Cytochalasin H [53760-19-3]1 mgBioViotica
AG-CR1-0045-M005Dynasore [304448-55-31]5 mgAdipoGen
AG-CR1-3613-G001Glyburide (USP) [10238-21-8]1 gAdipoGen
AG-CN2-0038-C100Ilimaquinone [71678-03-0]100 ugAdipoGen
AG-CN2-0459-M010Isoliquiritigenin [961-29-5]10 mgAdipoGen
AG-CN2-0037-C050Jasplakinolide (high purity) [102396-24-7]50 ugAdipoGen
AG-CN2-0027-C100Latrunculin A [76343-93-6]100 ugAdipoGen
AG-CN2-0031-M001Latrunculin B [76343-94-7]1 mgAdipoGen
AG-CR1-3615-M001MCC950 . sodium salt [256373-96-3]1 mgAdipoGen
AG-CR1-0019-M005Nocodazole [31430-18-9]5 mgAdipoGen
AG-CN2-0045-M001Paclitaxel [33069-62-4]1 mgAdipoGen
AG-CN2-0455-M010Parthenolide [20554-84-1]10 mgAdipoGen
AG-CN2-0049-M100Podophyllotoxin [518-28-5]100 mgAdipoGen
AG-CL1-0001-M001Prostaglandin E2 [363-24-6]1 mgAdipoGen
AG-CN2-0083-C100Pseudolaric acid B [82508-31-4]100 ugAdipoGen
AG-CN2-0033-M050Resveratrol [501-36-0]50 mgAdipoGen
AG-CN2-0440-C500Sceptrin . dihydrochloride [79703-25-6]500 ugAdipoGen
AG-CN2-0035-C010Swinholide A [95927-67-6]10 ugAdipoGen
AG-CN2-0074-M005Thiocolchicine [2730-71-4]5 mgAdipoGen
AG-CN2-0454-M020Vinpocetine [42971-09-5]20 mgAdipoGen
AG-CN2-0490-M001Withaferin A [5119-48-2]1 mgAdipoGen



Source:
Brochure: Innate Immunity, Inflammasome Wallchart, Inflammasome Signaling

Related to:
Brands: AdipoGen Life Sciences, Innaxon
Product groups: Antibodies, Chemicals, Proteins / Signaling Molecules